Product Program year 2025 Source: CMS Open Payments

Unloxcyt

Drug Oncology

NDC 70095-130-01

Open in the dashboard

General payments

$516,979

464 payments

Research payments

$0

0 payments

Through program year 2025, $516,979 in general payments and $0 in research payments were reported against Unloxcyt (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $516,979 464

Breakdown

Who paid General payments · program year 2025
  1. Sun Pharmaceutical Industries Inc. $516,979 464 payments
Top recipients General payments · program year 2025
  1. Ann Silk Medical Oncology · Boston, MA $27,669 5% · 24 payments
  2. David Miller Dermatology · Boston, MA $23,958 5% · 17 payments
  3. Michael Migden Dermatology · Houston, TX $19,775 4% · 15 payments
  4. Emily Ruiz Dermatology · Boston, MA $19,648 4% · 10 payments
  5. Brent Moody MOHS-Micrographic Surgery · Nashville, TN $19,428 4% · 19 payments

The top 5 of 56 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $170,839 33% · 16 practitioners
  2. Medical Oncology Internal Medicine $162,512 32% · 14 practitioners
  3. Hematology & Oncology Internal Medicine $73,564 14% · 10 practitioners
  4. MOHS-Micrographic Surgery Dermatology $66,315 13% · 8 practitioners
  5. Internal Medicine $18,122 4% · 2 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $83,666 16% · 9 recipients
  2. Massachusetts $71,275 14% · 3 recipients
  3. Florida $55,036 11% · 5 recipients
  4. New Jersey $37,385 7% · 4 recipients
  5. Maryland $26,639 5% · 2 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

464 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record